Daniel Hume insider trades

Open-market stock purchases and sales by Daniel Hume, Director at TG Therapeutics, Inc, from SEC Form 4 filings since Jul 6, 2016.

Recent trades

DateStockTradeValue
Jun 11, 2026TGTX TG Therapeutics, IncBought (not open market)—

Companies traded

  • TGTX TG Therapeutics, Inc: other filings, last Jun 11, 2026
  • NHLD National Holdings Corp: other filings, last Feb 25, 2021
  • STML Stemline Therapeutics Inc: other filings, last Jun 10, 2020

Get free alerts when Daniel Hume files a new trade →